TITLE

Clinicopathological study of centrally necrotizing carcinoma of the breast

AUTHOR(S)
Yanling Zhang; Yurong Ou; Donghong Yu; Xiang Yong; Xiaoli Wang; Bo Zhu; Qiong Zhang; Lei Zhou; Zhaogen Cai; Zenong Cheng
PUB. DATE
April 2015
SOURCE
BMC Cancer;2015, Vol. 15 Issue 1, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Centrally necrotizing carcinoma of the breast (CNC) represents a newly-identified subset of breast cancer. The clinical and pathological characteristics of this breast cancer subtype are not yet completely understood. Methods: We assessed the clinicopathological characteristics of 73 cases of CNC and 30 control cases of high-grade infiltrating ductal carcinoma (IDC) with focal necrosis based on light microscopy and immunohistochemical staining for estrogen receptor, progesterone receptor, Cerb-B2/HER2, Ki-67, epidermal growth factor receptor, cytokeratin 5/6, smooth muscle actin, S-100 protein, p63 and CD10. Results: All the tumors showed extensive central necrotic or acellular zones with different degrees of fibrotic or hyaline material surrounded by ring-like or ribbon-like residual tumour tissue which were usually high-grade IDCs. The central necrotic zone accounted for at least 30% of the cross-sectional area of the tumor. Thirty-six cases (49.3%) showed a component of ductal carcinoma in situ. The tumorous stroma around the central necrotic zone was accompanied by myxoid matrix formation in 28 cases (40%). Lymphocytic infiltration was present in 53 cases (72.6%). Granulomatous reactions were detected at the periphery of the tumors in 49 cases (67.1%). Immunohistochemistry showed greater expression of basal-like markers (72.2%, 52 cases) than myoepithelial markers (60.6%, 43 cases), both of which were significantly higher than in controls (26.7%, 8 cases) (P < 0.001). According to molecular typing, most CNCs were basal-like subtype (37 cases, 50.7%). Follow-up data were available for 28 patients. Disease progression occurred in 11 patients. The combined rate of recurrence, distant metastasis or death was significantly higher in CNC patients compared with controls (P < 0.05). Conclusions: CNC was associated with distinctive clinicopathologic features mostly characterized as basal-like type. Its high proliferative activity, highly-aggressive biological behavior, and high rates of recurrence and metastasis, suggest that CNC should be classified as a new type of breast carcinoma.
ACCESSION #
102611324

 

Related Articles

  • Vimentin as a poor prognostic factor for triple-negative breast cancer. Yamashita, Nami; Tokunaga, Eriko; Kitao, Hiroyuki; Hisamatsu, Yuichi; Taketani, Kenji; Akiyoshi, Sayuri; Okada, Satoko; Aishima, Shinichi; Morita, Masaru; Maehara, Yoshihiko // Journal of Cancer Research & Clinical Oncology;May2013, Vol. 139 Issue 5, p739 

    Purpose: Triple-negative breast cancer (TNBC), characterized by the absence of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2, is a highly heterogeneous disease. Recent studies suggest that there are links between TNBC and the epithelial-mesenchymal...

  • Morphological profile and receptor status in breast carcinoma: An institutional study. Rao, Chandrika; Shetty, Jayaprakash; HL, Kishan Prasad // Journal of Cancer Research & Therapeutics;Jan-Mar2013, Vol. 9 Issue 1, p44 

    Context: The data on histological and receptor status in breast cancer in an Indian population is limited as receptor status is not routinely carried out for these patients. In the present study, receptor status was analyzed and it was correlated with morphological prognostic parameters....

  • Molecular subtypes in ductal carcinoma in situ of the breast and their relation to prognosis: a population-based cohort study. Wenjing Zhou; Jirström, Karin; Amin, Rose-Marie; Fjällskog, Marie-Louise; Sollie, Thomas; Lindman, Henrik; Sørlie, Therese; Blomqvist, Carl; Wärnberg, Fredrik // BMC Cancer;2013, Vol. 13 Issue 1, p1 

    Background Different molecular subtypes of breast cancer have been identified based on gene expression profiling. Treatment suggestions based on an approximation of these subtypes by immunohistochemical criteria have been published by the St Gallen international expert consensus panel. Ductal...

  • Immunophenotypes of Glycogen Rich Clear Cell Carcinoma. Sung Eun Kim; Ja Seung Koo; Woo-Hee Jung // Yonsei Medical Journal;Nov2012, Vol. 53 Issue 6, p1142 

    Purpose: Glycogen rich clear cell carcinoma (GRCC) of the breast is a rare subtype of invasive ductal carcinoma and involves a poor prognosis. In the literature, less than 150 cases have been reported. Many researchers have attempted to characterize GRCC according to electron microscope, flow...

  • Unique clinicopathological features of metaplastic breast carcinoma compared with invasive ductal carcinoma and poor prognostic indicators. Yanni Song; Xiaolong Liu; Guoqiang Zhang; Hongtao Song; Ren, Yanlv; Xiaoguang He; Yanbo Wang; Jinfeng Zhang; Youxue Zhang; Shanshan Sun; Xiaoshuan Liang; Qian Sun; Da Pang // World Journal of Surgical Oncology;2013, Vol. 11 Issue 1, p1 

    Background: Metaplastic breast carcinoma is a rare aggressive malignant neoplasm. The purposes of this study are to review the pathologic features and clinical outcomes of metaplastic breast carcinoma compared to invasive ductal carcinoma and to evaluate the prognosis of metaplastic breast...

  • Prognostic factors in metaplastic carcinoma of the breast: a multi-institutional study. Rakha, E A; Tan, P H; Varga, Z; Tse, G M; Shaaban, A M; Climent, F; van Deurzen, C H M; Purnell, D; Dodwell, D; Chan, T; Ellis, I O // British Journal of Cancer;1/20/2015, Vol. 112 Issue 2, p283 

    Background:Metaplastic breast carcinoma (MBC) is a rare type of breast cancer that has basal-like characteristics and is perceived to have poorer prognosis when compared with conventional no specific type/ductal carcinomas (ductal/NST). However, current data on MBC are largely derived from small...

  • Triple-Negatif/Bazal Benzeri Meme Kanserinin Ä°mmünohistokimyasal Özellikleri. PALA, Emel Ebru; BAYOL, Ümit; CUMURCU, Süheyla; KESKİN, Elif // Turkish Journal of Pathology;2012, Vol. 28 Issue 3, p238 

    Objective: Triple-negative-breast-cancer that accounts for 10-20% of all breast carcinomas is defined by the lack of estrogen receptor, progesterone receptor, HER2 expression, and agressive clinical behavior. Triple-negative-breast-cancer is categorized into basal like and other types. The...

  • Lack of prognostic significance of adiponectin immunohistochemical expression in patients with triple-negative breast cancer. Cubukcu, Erdem; Olmez, Omer Fatih; Kanat, Ozkan; Kabul, Selva; Canhoroz, Mustafa; Avci, Nilufer; Hartavi, Mustafa; Deligonul, Adem; Çubukçu, Sinem; Manavoglu, Osman // Contemporary Oncology / Wspolczesna Onkologia;2014, Vol. 18 Issue 1, p34 

    Introduction: Triple-negative breast cancers (TNBCs) - which lack the expression of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER-2) - have no established markers that can be used for prognostic stratification. As adiponectin has been...

  • Biology matters: the clinical impact of single-receptor discordance on breast cancer. Farolfi, A.; Ibrahim, T.; Scarpi, E.; Amadori, D. // Annals of Oncology;Mar2013, Vol. 24 Issue 3, p851 

    No abstract available.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics